Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis

被引：115
|
作者：
Qureshi, AI
Choudhry, MA
Akbar, MS
Mohammad, Y
Chua, HC
Yahia, AM
Ulatowski, JA
Krendel, DA
Leshner, RT
机构：
[1] Johns Hopkins Hosp, Dept Neurol, Baltimore, MD USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurol, Richmond, VA 23298 USA
[3] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA USA
[4] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA
来源：
NEUROLOGY | 1999年 / 52卷 / 03期
关键词：
D O I：
10.1212/WNL.52.3.629
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We performed a retrospective multicenter chart review to compare the efficacy and tolerance of plasma exchange (PE) and intravenous immunoglobulin (IVIg) in treatment of 54 episodes of myasthenic crisis. After adjustment for other variables, PE (compared with Mg) was associated with a superior ventilatory status at 2 weeks (partial F = 6.2, p = 0.02) and 1 month functional outcome (partial F = 4.5, p = 0.04). However, the complication rate was higher with PE compared with IVIg (13 versus 5 episodes, p = 0.07).
引用
收藏
页码：629 / 632
页数：4
相关论文
共 50 条
  • [1] Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: A prospective cohort study
    Wang, Yuan
    Huan, Xiao
    Jiao, Kexin
    Jiang, Qilong
    Goh, Li-Ying
    Shi, Jianquan
    Lv, Zhiguo
    Xi, Jianying
    Song, Jie
    Yan, Chong
    Lin, Jie
    Zhu, Wenhua
    Zhu, Xinfang
    Zhou, Zhirui
    Xia, Rong
    Luo, Sushan
    Zhao, Chongbo
    CLINICAL IMMUNOLOGY, 2022, 241
  • [2] Intravenous immunoglobulin versus plasmapheresis for myasthenic crisis
    Choudhry, MA
    Qureshi, AI
    Akbar, MS
    Ulatowski, JA
    Leshner, RT
    DeLorenzo, RJ
    NEUROLOGY, 1998, 50 (04) : A433 - A433
  • [3] Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis
    Ma, Jing
    Zhang, Huiqiu
    Zhao, Junsen
    Su, Menghan
    Feng, Yingna
    Yuan, Xiaoli
    Liu, Dan
    Pang, Xiaomin
    Zhao, Rongjuan
    Wang, Juan
    Duan, Weisong
    Chang, Xueli
    Guo, Junhong
    Zhang, Wei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Therapeutic plasma exchange in a patient of myasthenic crisis, refractory to intravenous immunoglobulin and immunosuppressive therapy
    Prakash, Satya
    Hans, Rekha
    Sharma, Ratti R.
    Lal, Vivek
    Marwaha, Neelam
    NEUROLOGY INDIA, 2017, 65 (06) : 1409 - +
  • [5] Intravenous Immunoglobulin Treatment in the Management of Myasthenic Crisis: Case Report
    Salman, Ebru
    Yetisir, Fahri
    Yurekli, Banu
    Bozkurt, Alper
    Kilic, Mehmet
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2013, 4 : 352 - 354
  • [6] Plasma exchange versus immunoglobulin infusion therapy in myasthenic crisis. Report of three cases
    Inghilleri, M
    Perinelli, D
    Francia, A
    Fabri, S
    Cruccu, G
    Manfredi, M
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1999, 21 (02): : 44 - 46
  • [7] Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration
    Schneider-Gold, Christiane
    Krenzer, Marco
    Klinker, Erdmute
    Mansouri-Thalegani, Behrouz
    Muellges, Wolfgang
    Toyka, Klaus V.
    Gold, Ralf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (04) : 297 - 303
  • [8] Comparison of plasma exchange, intravenous immunoglobulin, and plasma exchange followed by intravenous immunoglobulin in the treatment of Guillain-Barre syndrome
    不详
    ANNALS OF NEUROLOGY, 1995, 38 (06) : 4 - 4
  • [9] Comparison of plasma exchange, intravenous immunoglobulin, and plasma exchange followed by intravenous immunoglobulin in the treatment of Guillain-Barre syndrome
    Hughes, RAC
    ANNALS OF NEUROLOGY, 1996, 40 (03) : T236 - T236
  • [10] Prognostic factors and efficacy of conventional plasma exchange in treatment of myasthenic crisis
    Zanaty, M. A. F.
    Al-Hendy, A. Yasser
    Ghonemy, A. Tarek
    Abdelhafez, Alla
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (08): : 690 - 690
12345